Turning play into therapy: Ride-On toys may boost arm strength in kids with hemiplegia

NCT ID NCT06579027

Ongoing Symptom relief Sponsor: University of Connecticut Source: ClinicalTrials.gov ↗

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This pilot study tests whether a home-based training program using joystick-operated ride-on toys can help children aged 3-8 with hemiplegia improve arm function. Children will use their affected arm to drive the toy through playful challenges, compared to a creative upper extremity training program. The study will assess feasibility, satisfaction, and changes in arm use and grip strength.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: A home-based training program using joystick-operated ride-on toys (SPEED training) compared to creative upper extremity training (CRAFT)
What this could lead to: If successful, this could offer a fun, child-friendly way to improve arm function and encourage use of the affected arm in daily activities for children with hemiplegia.
What could go wrong: This is a small pilot study focused on feasibility, not proof of effectiveness. Results may not generalize, and the training may not lead to significant motor improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL PALSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral palsy cerebral palsy spastic hemiplegic hemiplegia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CEREBRAL PALSY CHILDREN, ONLY HEMIPLEGIA

Contacts and locations

Locations

Physical Therapy Program, Department of Kinesiology, University of Connecticut

Storrs, Connecticut, 06269, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.